SCM
ACET icon

Segantii Capital Management’s Adicet Bio ACET Stock Holding History

Segantii Capital Management’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-6,714
Closed -$6.65M – 77
2019
Q3 		$6.65M Buy
6,714
+338
+5% +$377K 0.9% 24
2019
Q2 		$7.28M Sell
6,376
-2,106
-25% -$1.91M 0.64% 22
2019
Q1 		$6.48M Buy
8,482
+1,859
+28% +$1.69M 0.76% 24
2018
Q4 		$6.39M Buy
6,623
+2,336
+54% +$3.08M 0.53% 13
2018
Q3 		$7.27M Buy
4,287
+1,352
+46% +$1.76M 3.85% 7
2018
Q2 		$3.01M Buy
2,935
+1,105
+60% +$1.19M 1.25% 20
2018
Q1 		$1.96M Buy
+1,830
New +$3.36M 0.48% 30

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Segantii Capital Management's ACET Position: Q4 2019 in Review

Segantii Capital Management sold out of Adicet Bio (ACET) in Q4 2019, closing a stake of 6,714 shares — an estimated $6.65M sold.

Segantii Capital Management first reported a position in ACET in Q1 2018 and held it in 7 quarters. The position peaked at $7.28M in Q2 2019. 54 funds tracked by Wall St. Rank hold ACET as of Q4 2019.

  • Segantii Capital Management reported no remaining Adicet Bio position as of Q4 2019 after selling out during the quarter.
  • Segantii Capital Management sold 6,714 Adicet Bio shares in Q4 2019, an estimated $6.65M.
  • Segantii Capital Management first reported a position in Adicet Bio in Q1 2018 and held it in 7 quarters.
  • Segantii Capital Management's Adicet Bio position peaked at $7.28M in Q2 2019.
  • 54 funds tracked by Wall St. Rank held Adicet Bio as of Q4 2019.

Based on Segantii Capital Management's 13F filing for Q4 2019, filed 30 Jan 2020.